Anda di halaman 1dari 2

Federal Register / Vol. 72, No.

10 / Wednesday, January 17, 2007 / Notices 1999

than 40 discretionary grant programs. protect the integrity of the grantee applicant to describe how these
The proposed information collection selection process. All ACF discretionary objectives will be achieved; along with
form would be a uniform discretionary grant programs would be eligible but not assurances and certifications. Guidance
application form eligible for use by required to use this application form. for the content of information requested
grant applications to submit project The application consists of general in the Project Description is found in
information in response to ACF program information and instructions; the OMB Circulars A–102 and A–110.
announcements. ACF would use this Standard Form 424 series that requests
Respondents: Applicants for ACF
information, along with other OMB- basic information, budget information,
approved information collections, to budget information and assurances; the Discretionary Grant Programs.
evaluate and rank applicants and Project Description requesting the

ANNUAL BURDEN ESTIMATES


Average bur-
Number of
Number of den Total burden
Instrument responses per
respondents hours per hours
respondent response

UPD ................................................................................................................. 11,960 1 40 478,400

Estimated Total Annual Burden DEPARTMENT OF HEALTH AND ADDRESSES: Submit written requests for
Hours: 478,400. HUMAN SERVICES single copies of the draft guidance to the
In compliance with the requirements Office of Communication, Training, and
Food and Drug Administration Manufacturers Assistance (HFM–40),
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Center for Biologics Evaluation and
[Docket No. 2006D–0514] Research (CBER), Food and Drug
Administration for Children and
Administration, 1401 Rockville Pike,
Families is soliciting public comment Draft Guidance for Industry: Minimally suite 200N, Rockville, MD 20852–1448.
on the specific aspects of the Manipulated, Unrelated, Allogeneic Send one self-addressed adhesive label
information collection described above. Placental/Umbilical Cord Blood to assist the office in processing your
Copies of the proposed collection of Intended for Hematopoietic requests. The draft guidance may also be
information can be obtained and Reconstitution in Patients with obtained by mail by calling CBER at 1–
comments may be forwarded by writing Hematological Malignancies; 800–835–4709 or 301–827–1800. See
to the Administration for Children and Availability the SUPPLEMENTARY INFORMATION section
Families, Office of Administration, for electronic access to the draft
Office of Information Services, 370 AGENCY: Food and Drug Administration, guidance document.
L’Enfant Promenade, SW., Washington, HHS. Submit written comments on the draft
DC 20447, Attn: ACF Reports Clearance ACTION: Notice. guidance to the Division of Dockets
Officer. E-mail address: Management (HFA–305), Food and Drug
infocollection@acf.hhs.gov. All requests SUMMARY: The Food and Drug Administration, 5630 Fishers Lane, rm.
should be identified by the title of the Administration (FDA) is announcing the 1061, Rockville, MD 20852. Submit
information collection. availability of a draft document entitled electronic comments to http://
‘‘Guidance for Industry: Minimally www.fda.gov/dockets/ecomments.
The Department specifically requests Manipulated, Unrelated, Allogeneic
comments on: (a) Whether the proposed FOR FURTHER INFORMATION CONTACT:
Placental/Umbilical Cord Blood Kathleen E. Swisher, Center for
collection of information is necessary Intended for Hematopoietic
for the proper performance of the Biologics Evaluation and Research
Reconstitution in Patients with (HFM–17), Food and Drug
functions of the agency, including Hematological Malignancies’’ dated Administration, 1401 Rockville Pike,
whether the information shall have December 2006. The draft guidance suite 200N, Rockville, MD 20852–1448,
practical utility; (b) the accuracy of the document provides recommendations 301–827–6210.
agency’s estimate of the burden of the that would allow the manufacturer,
SUPPLEMENTARY INFORMATION:
proposed collection of information; (c) generally a cord blood bank, to apply for
the quality, utility, and clarity of the licensure of minimally manipulated, I. Background
information to be collected; and (d) unrelated, allogeneic placental/ FDA is announcing the availability of
ways to minimize the burden of the umbilical cord blood, for specified a draft document entitled ‘‘Guidance for
collection of information on indications. The document also contains Industry: Minimally Manipulated,
respondents, including through the use information about the manufacture of Unrelated, Allogeneic Placental/
of automated collection techniques or minimally manipulated, unrelated, Umbilical Cord Blood Intended for
other forms of information technology. allogeneic placental/umbilical cord Hematopoietic Reconstitution in
Consideration will be given to blood and how to comply with Patients with Hematological
comments and suggestions submitted applicable regulatory requirements. Malignancies’’ dated December 2006.
within 60 days of this publication. DATES: Submit written or electronic The draft guidance document provides
mstockstill on PROD1PC61 with NOTICES

Dated: January 11, 2007. comments on the draft guidance by recommendations that would allow the
April 17, 2007 to ensure their adequate manufacturer, generally a cord blood
Robert Sargis,
consideration in preparation of the final bank, to apply for licensure of
Reports Clearance Officer. guidance. General comments on agency minimally manipulated, unrelated,
[FR Doc. 07–127 Filed 1–16–07; 8:45 am] guidance documents are welcome at any allogeneic placental/umbilical cord
BILLING CODE 4184–01–M time. blood, for specified indications. The

VerDate Aug<31>2005 13:58 Jan 16, 2007 Jkt 211001 PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 E:\FR\FM\17JAN1.SGM 17JAN1
2000 Federal Register / Vol. 72, No. 10 / Wednesday, January 17, 2007 / Notices

guidance document provides guidance. Submit a single copy of Executive Office Building, Washington,
recommendations for the submission of electronic comments or two paper DC 20503; fax: 202–395–6974.
a biologics license application for copies of any mailed comments, except FOR FURTHER INFORMATION CONTACT:
placental/umbilical cord blood products that individuals may submit one paper Lillian Deitzer, Departmental Reports
that are: (1) Manipulated minimally; (2) copy. Comments are to be identified Management Officer, QDAM,
used for hematopoietic reconstitution in with the docket number found in the Department of Housing and Urban
patients with hematological brackets in the heading of this Development, 451 Seventh Street, SW.,
malignancies; and (3) used in recipients document. A copy of the draft guidance Washington, DC 20410; e-mail
unrelated to the donor. The document and received comments are available for Lillian_L._Deitzer@HUD.gov or
also contains information about the public examination in the Division of telephone (202) 708–2374. This is not a
manufacture of minimally manipulated, Dockets Management between 9 a.m. toll-free number. Copies of available
unrelated, allogeneic placental/ and 4 p.m., Monday through Friday. documents submitted to OMB may be
umbilical cord blood and how to obtained from Ms. Deitzer or from
IV. Electronic Access
comply with applicable regulatory HUD’s Web site at http://
requirements. For the manufacture of Persons with access to the Internet hlannwp031.hud.gov/po/i/icbts/
peripheral blood or cord hematopoietic may obtain the draft guidance at either collectionsearch.cfm.
stem/progenitor cells other than those http://www.fda.gov/cber/guidelines.htm
described, the manufacturer may need or http://www.fda.gov/ohrms/dockets/ SUPPLEMENTARY INFORMATION: This
to submit an investigational new drug default.htm. notice informs the public that the
application or other premarketing Department of Housing and Urban
Dated: January 10, 2007.
application for that product. Development has submitted to OMB a
Jeffrey Shuren, request for approval of the information
The draft guidance is being issued
Assistant Commissioner for Policy. collection described below. This notice
consistent with FDA’s good guidance
[FR Doc. E7–549 Filed 1–16–07; 8:45 am] is soliciting comments from members of
practices regulation (21 CFR 10.115).
The draft guidance, when finalized, will BILLING CODE 4160–01–S the public and affecting agencies
represent FDA’s current thinking on this concerning the proposed collection of
topic. It does not create or confer any information to: (1) Evaluate whether the
rights for or on any person and does not proposed collection of information is
DEPARTMENT OF HOUSING AND
operate to bind FDA or the public. An necessary for the proper performance of
URBAN DEVELOPMENT
alternative approach may be used if the functions of the agency, including
such approach satisfies the requirement [Docket No. FR–5117–N–02] whether the information will have
of the applicable statutes and practical utility; (2) Evaluate the
regulations. Notice of Submission of Proposed accuracy of the agency’s estimate of the
Information Collection to OMB; burden of the proposed collection of
II. Paperwork Reduction Act of 1995 Multifamily Housing Service information; (3) Enhance the quality,
This draft guidance refers to Coordinator Program utility, and clarity of the information to
previously approved collections of be collected; and (4) Minimize the
AGENCY: Office of the Chief Information burden of the collection of information
information found in FDA regulations.
Officer, HUD. on those who are to respond; including
These collections of information are
subject to review by the Office of ACTION: Notice. through the use of appropriate
Management and Budget (OMB) under automated collection techniques or
SUMMARY: The proposed information
the Paperwork Reduction Act of 1995 other forms of information technology,
collection requirement described below e.g., permitting electronic submission of
(44 U.S.C. 3501–3520). The collections has been submitted to the Office of
of information in 21 CFR part 201 have responses.
Management and Budget (OMB) for This notice also lists the following
been approved under OMB Control No. review, as required by the Paperwork
0910–0572; 21 CFR part 211 have been information:
Reduction Act. The Department is Title of Proposal: Multifamily
approved under OMB Control No. 0910– soliciting public comments on the
0139; 21 CFR part 600 have been Housing Service Coordinator Program.
subject proposal. OMB Approval Number: 2502–0447.
approved under OMB Control No. 0910– Housing project owners/managers
0308; 21 CFR parts 601, 610, and FDA Form Numbers: SF–424, SF–424–
apply for grants under the Housing Supp, SF–LLL, HUD–2880, HUD–2993,
Form 356(h) have been approved under Service Coordinator Program. The
OMB Control No. 0910–0338; 21 CFR HUD–2994–A, HUD–96010, HUD–
requested information will assist HUD 92456, HUD–50080–SCMF–HUD–
part 1271 have been approved under in evaluating grant applicants and to
OMB Control Nos. 0910–0559, 0910– 91186, SF–269–A, and HUD–91186–A.
determine how well grant funds meet Description of the Need for the
0469, and 0910–0543; and FDA Form stated program goals and how well the
3500A has been approved under OMB Information and Its Proposed Use:
public was served. Housing project owners/manages apply
Control No. 0910–0291.
DATES: Comments Due Date: February for grants under the Housing Service
III. Comments 16, 2007. Coordinator Program. The requested
The draft guidance is being ADDRESSES: Interested persons are information will assist HUD in
distributed for comment purposes only invited to submit comments regarding evaluating grant applicants and to
and is not intended for implementation this proposal. Comments should refer to determine how well grant funds meet
at this time. Interested persons may the proposal by name and/or OMB stated program goals and how well the
mstockstill on PROD1PC61 with NOTICES

submit to the Division of Dockets approval Number (2502–0447) and public was served.
Management (see ADDRESSES) written or should be sent to: HUD Desk Officer, Frequency of Submission: Quarterly,
electronic comments regarding the draft Office of Management and Budget, New Semi-annually, Annually.

VerDate Aug<31>2005 13:58 Jan 16, 2007 Jkt 211001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 E:\FR\FM\17JAN1.SGM 17JAN1

Anda mungkin juga menyukai